Pharma Stocks

Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More

Pharma Stocks Recent News

Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed'
One of the bestselling medical drugs of all time has come off patent. The result could mean lower costs for those who need the drug as a treatment option. Enter Mark Cuban and his Cost Plus Drug Company, which announced a new initiative Thursday.
Jim Cramer Hates Being 'Downbeat,' But Warns: Default On Debt Would Affect Geopolitical Face Of US
6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
Rocket Pharma (NASDAQ: RCKT) CEO Gaurav Shah is on a mission to "change the narrative" when it comes to rare diseases.
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
Jim Simons is the founder and hedge fund manager of Renaissance Technologies, which currently has a total portfolio value north of $77 billion, per Stock Circle. This hedge fund uses a quantitative strategy in determining its stock trades.
Microvast, AMC, Moderna, Clover Health, Pfizer, And More — Stocks Buzzing On WallStreetBets Today
Microvast Holdings Inc. (NASDAQ: MVST) remains the most-discussed stock on Reddit’s r/WallStreetBets forum as of Tuesday night, while AMC Entertainment Holdings Inc. (NYSE: AMC), Moderna Inc. (NASDAQ:
What's Up With Novavax Stock?
Novavax, Inc (NASDAQ: NVAX) shares closed 12.24% higher in the regular session on Monday. What Happened: The biotechnology company working on a COVID-19 vaccine saw its shares move 0.74% higher in the after-hours trading.
Moderna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck
Moderna Inc (NASDAQ: MRNA), a company founded in 2010, is now worth more than the 130-year old Merck & Co., Inc (NYSE: MRK) in terms of market capitalization.
CVS, Walgreens, Rite Aid Shares Fall On Report Of Potential Amazon Entry Into Retail Pharmacy
CVS (NYSE: CVS), Walgreens (NASDAQ: WBA) and Rite Aid (NYSE: RAD) shares lost ground Wednesday after a 
Private Equity EQT Offers To Acquire Swedish Pharma Recipharm For $2.1B
Stockholm headquartered private equity group EQT AB will buy Swedish pharma company Recipharm AB for $2.1 billion, according to company's
Pfizer Applies For Emergency Approval For COVID-19 Vaccine In India: Media Reports
Pfizer Inc. (NYSE: PFE) is seeking emergency approval for its COVID-19 vaccine in India, according to media sources in the country.
UK To Approve Pfizer-BioNTech Vaccine 'Within Days,' Secures 2M More Doses From Moderna
The U.K.
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the Thanksgiving holiday.
Pfizer: SEC Foreign-Bribery Unit Has Formally Asked Company For Info
Pfizer Inc. (NYSE: PFE) has disclosed in its earnings report that it received an official request for information from the US Securities and Exchange Commission, according to The Wall S
Johnson & Johnson Downplayed Opioid Drugs' Side Effects, New York Unveils Charges
New York Governor Andrew Cuomo on Thursday announced the state has filed civil charges against Johnson & Johnson (NYSE: JNJ), accusing it of insurance fraud in connection with understating the risks posed by opioid drugs to doctors and elderly patients. 
Bayer Settles Most Cases Related To Roundup Herbicide For Up To $10.9B
Bayer AG (OTC: BAYRY) will pay between $10.1 to $10.9 billion to resolve litigation over the weedkiller Roundup. 
Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July
Johnson & Johnson (NYSE: JNJ) will begin the human clinical trials of its novel coronavirus (COVID-19) vaccine in July, the company announced
Novavax Begins Phase 1 Clinical Trial Of Its Coronavirus Vaccine
Novavax Inc. (NASDAQ: NVAX) announced on Monday it had started the first phase of its novel coronavirus (COVID-19) vaccine trials.
Teladoc Narrows Loss In Q1 As Coronavirus Causes Demand Surge For Remote Health Services
Teladoc Health Inc. (NYSE: TDOC) on Wednesday reported that it reduced losses in the first quarter compared to a year ago, as the novel coronavirus (COVID-19) pandemic caused a surge in demand for its services.
Novartis' Sandoz To Pay $195M For Price-Fixing
New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA
Pharma Companies Shares Tank As Feds Investigate Opioid Crisis
Barron's Picks And Pans: Pfizer's New Identity, Electric Vehicles, Hong Kong Exodus — And Is The Bull Market About To End?
Analysts See Allergan Bid Of Over $180, Possibility of 'Hostile' Bid

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved